The Terrible Triad of Checkpoint Inhibition: A Case Report of Myasthenia Gravis, Myocarditis, and Myositis Induced by Cemiplimab in a Patient with Metastatic Cutaneous Squamous Cell Carcinoma

BACKGROUND: We report a case of a patient with squamous cell carcinoma (SCC) who developed myasthenia gravis (MG), myositis, and myocarditis after receiving cemiplimab, an anti-PD-1 immune checkpoint inhibitor (ICI). Case Presentation. An 86-year-old man with metastatic periocular SCC presented with...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Case Reports Immunol
Main Authors: Jeyakumar, Nikeshan, Etchegaray, Mikel, Henry, Jason, Lelenwa, Laura, Zhao, Bihong, Segura, Ana, Buja, L. Maximilian
Format: Artigo
Jezik:Inglês
Izdano: Hindawi 2020
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7355354/
https://ncbi.nlm.nih.gov/pubmed/32695533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/5126717
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki